Please use this identifier to cite or link to this item:
Title: Preliminary Results from TOPAZ-III, A Phase 3b Study Evaluating the Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir +/- Ribavirin in Naive or Experienced Adults in Brazil with HCV Genotype 1 Infection and Advanced Fibrosis/Cirrhosis
Authors: PESSOA, Mario G.RAMALHO, Jose Valdez MadrugaALVES, KatiaCOHEN, Daniel E.NUNES, Estevao PortelaCHEINQUER, HugoBRANDAO-MELLO, Carlos E.MENDES-CORREA, Maria CassiaFERRAZ, Maria Lucia G.LARI, SaraLUI, LiTRIPATHI, RakeshPILOT-MATIAS, TamiSCHULMAN, NancyMARTINELLI, Ana L.
Citation: HEPATOLOGY, v.64, suppl.1, p.949A-950A, 2016
Appears in Collections:

Comunicações em Eventos - FM/MIP
Departamento de Moléstias Infecciosas e Parasitárias - FM/MIP

Comunicações em Eventos - HC/ICHC
Instituto Central - HC/ICHC

Comunicações em Eventos - LIM/52
LIM/52 - Laboratório de Virologia

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.